J M Brophy

Summary

Affiliation: McGill University
Country: Canada

Publications

  1. ncbi The interpretation of systematic reviews with meta-analyses: an objective or subjective process?
    Ian Shrier
    Centre for Clinical Epidemiology and Community Studies, Lady Davis Institute for Medical Research, SMBD Jewish General Hospital, McGill University, Montreal, Canada
    BMC Med Inform Decis Mak 8:19. 2008
  2. ncbi The potential interaction between clopidogrel and proton pump inhibitors: a systematic review
    Joao Paulo de Aquino Lima
    Federal University of Ceará School of Medicine, Fortaleza, Brazil
    BMC Med 8:81. 2010
  3. ncbi Acute ischemic heart disease and interventional cardiology: a time for pause
    Peter Bogaty
    Quebec Heart Institute Laval Hospital, Laval University, 2725 Chemin Ste Foy, Quebec, G1V 4G5, Canada
    BMC Med 4:25. 2006
  4. ncbi Validity of electron beam computed tomography for coronary artery disease: asystematic review and meta-analysis
    Nandini Dendukuri
    Technology Assessment Unit, McGill University Health Center, 687 Pine Avenue West R4, 09, Montreal, PQ, H3A 1A1 Canada
    BMC Med 5:35. 2007
  5. ncbi The risk of death associated with delayed coronary artery bypass surgery
    Boris G Sobolev
    Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada
    BMC Health Serv Res 6:85. 2006
  6. ncbi Routine invasive management after fibrinolysis in patients with ST-elevation myocardial infarction: a systematic review of randomized clinical trials
    Peter Bogaty
    Institut Universitaire de Cardiologie et Pneumologie de Québec, Quebec, Canada
    BMC Cardiovasc Disord 11:34. 2011
  7. ncbi Lifestyle variables and the risk of myocardial infarction in the general practice research database
    Joseph A C Delaney
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada
    BMC Cardiovasc Disord 7:38. 2007
  8. ncbi Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials
    Kristian B Filion
    Department of Medicine, McGill University, Montreal, Quebec, Canada
    BMC Cardiovasc Disord 10:24. 2010
  9. ncbi Microvolt T-wave alternans as a predictor of mortality and severe arrhythmias in patients with left-ventricular dysfunction: a systematic review and meta-analysis
    Charlotte J van der Avoort
    Department of Medicine, McGill University Health Center, Montreal, Quebec, Canada
    BMC Cardiovasc Disord 9:5. 2009
  10. ncbi Cardiovascular effects of cyclooxygenase-2 inhibitors
    James M Brophy
    Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
    Curr Opin Gastroenterol 23:617-24. 2007

Detail Information

Publications77

  1. ncbi The interpretation of systematic reviews with meta-analyses: an objective or subjective process?
    Ian Shrier
    Centre for Clinical Epidemiology and Community Studies, Lady Davis Institute for Medical Research, SMBD Jewish General Hospital, McGill University, Montreal, Canada
    BMC Med Inform Decis Mak 8:19. 2008
    ..The objective of this study was to determine the discordance in interpretations when meta-analysts are presented with identical data...
  2. ncbi The potential interaction between clopidogrel and proton pump inhibitors: a systematic review
    Joao Paulo de Aquino Lima
    Federal University of Ceará School of Medicine, Fortaleza, Brazil
    BMC Med 8:81. 2010
    ..In an attempt to clarify the situation, we performed a systematic review with a critical analysis of study methodologies to determine whether varying study quality (that is, bias) could explain the discordant results...
  3. ncbi Acute ischemic heart disease and interventional cardiology: a time for pause
    Peter Bogaty
    Quebec Heart Institute Laval Hospital, Laval University, 2725 Chemin Ste Foy, Quebec, G1V 4G5, Canada
    BMC Med 4:25. 2006
    ....
  4. ncbi Validity of electron beam computed tomography for coronary artery disease: asystematic review and meta-analysis
    Nandini Dendukuri
    Technology Assessment Unit, McGill University Health Center, 687 Pine Avenue West R4, 09, Montreal, PQ, H3A 1A1 Canada
    BMC Med 5:35. 2007
    ..Our objective was to carry out a systematic review and meta-analysis of EBCT for the screening of asymptomatic patients and the diagnosis of symptomatic patients for CAD...
  5. ncbi The risk of death associated with delayed coronary artery bypass surgery
    Boris G Sobolev
    Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada
    BMC Health Serv Res 6:85. 2006
    ..Therefore, we sought to improve the estimates of the risk of death associated with delayed surgical treatment of coronary artery disease...
  6. ncbi Routine invasive management after fibrinolysis in patients with ST-elevation myocardial infarction: a systematic review of randomized clinical trials
    Peter Bogaty
    Institut Universitaire de Cardiologie et Pneumologie de Québec, Quebec, Canada
    BMC Cardiovasc Disord 11:34. 2011
    ..We sought to examine the randomized clinical trials (RCTs) on which this approach is based...
  7. ncbi Lifestyle variables and the risk of myocardial infarction in the general practice research database
    Joseph A C Delaney
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada
    BMC Cardiovasc Disord 7:38. 2007
    ..As a secondary objective, we considered the association between other lifestyle variables, smoking and heavy alcohol use, and AMI risk...
  8. ncbi Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials
    Kristian B Filion
    Department of Medicine, McGill University, Montreal, Quebec, Canada
    BMC Cardiovasc Disord 10:24. 2010
    ..A meta-analysis of these RCTs to estimate efficacy and safety and potential sources of heterogeneity may be helpful...
  9. ncbi Microvolt T-wave alternans as a predictor of mortality and severe arrhythmias in patients with left-ventricular dysfunction: a systematic review and meta-analysis
    Charlotte J van der Avoort
    Department of Medicine, McGill University Health Center, Montreal, Quebec, Canada
    BMC Cardiovasc Disord 9:5. 2009
    ..Microvolt T-wave alternans (MTWA) has been proposed to assist in this stratification...
  10. ncbi Cardiovascular effects of cyclooxygenase-2 inhibitors
    James M Brophy
    Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
    Curr Opin Gastroenterol 23:617-24. 2007
    ..Cardiotoxicity has been an adverse outcome of cyclooxygenase-2 inhibitors and this article will critically review the evidence...
  11. ncbi The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction
    J M Brophy
    Department of Epidemiology and Biostatistics, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
    Heart 93:189-94. 2007
    ....
  12. ncbi Pravastatin and cancer: an unproven association
    James M Brophy
    Division of Cardiology, Department of Medicine, , and CHUM/MUHC Technology Assessment Unit, Royal Victoria Hospital,
    CMAJ 176:646-7. 2007
  13. ncbi The benefit of cholesterol-lowering medications after coronary revascularization: a population study
    James M Brophy
    Department of Medicine, McGill University Health Center, McGill University, Montreal, Quebec, Canada
    Am Heart J 150:282-6. 2005
    ..In routine practice, the translation of these benefits to elderly patients with recent coronary revascularization is less well known...
  14. ncbi Cost-effectiveness of drug-eluting coronary stents in Quebec, Canada
    James M Brophy
    McGill University, Quebec, Canada
    Int J Technol Assess Health Care 21:326-33. 2005
    ..The aim of this investigation was to assess the incremental cost-effectiveness of replacing bare metal coronary stents (BMS) with drug-eluting stents (DES) in the Province of Quebec, Canada...
  15. ncbi Resource allocation among cardiovascular specialists and trainees: a pilot survey
    James M Brophy
    Department of Medicine, McGill University Health Centre, Montreal, Quebec, Canada
    Can J Cardiol 24:118-20. 2008
    ..To assess the relative importance that cardiovascular specialists assign to new technologies...
  16. ncbi Celecoxib and cardiovascular risks
    James M Brophy
    McGill University Health Centre, Division of Cardiology, Royal Victoria Hospital, Montreal, Quebec, H3A 1A1, Canada
    Expert Opin Drug Saf 4:1005-15. 2005
    ..Specific modifying factors of the cardiovascular risk of COX-2 inhibitors including dose, concomitant drugs, individual cardiac and genetic risk profiles, will require further study...
  17. ncbi A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention
    James M Brophy
    Division of Cardiology, Royal Victoria Hospital McGill University Health Center, Montreal, Quebec, Canada
    Am Heart J 152:263-9. 2006
    ....
  18. ncbi Statin wars following coronary revascularization--evidence-based clinical practice?
    James M Brophy
    Division of Cardiology, Royal Victoria Hospital McGill University Health Center, Montreal, Quebec
    Can J Cardiol 22:54-8. 2006
    ..Pharmaceutical companies spend enormous amounts of money on both clinical trials and marketing. The relative influence of information from clinical trials on physician prescription patterns for statins is unknown...
  19. ncbi Medical decision making with incomplete evidence--choosing a platelet glycoprotein IIbIIIa receptor inhibitor for percutaneous coronary interventions
    James M Brophy
    Division of Cardiology, Department of Medicine, and Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec
    Med Decis Making 25:222-8. 2005
    ..Substantial cost differentials are also present between the drugs...
  20. ncbi Primary angioplasty and thrombolysis are both reasonable options in acute myocardial infarction
    James M Brophy
    Division of Cardiology, McGill University Health Centre, McGill University, Montreal, Quebec, Canada
    Ann Intern Med 141:292-7. 2004
    ..Thrombolysis remains a clinically and economically attractive option for the treatment of acute myocardial infarction that does not require the radical restructuring of our health care systems...
  21. ncbi The use of cholesterol-lowering medications after coronary revascularization
    James M Brophy
    Department of Medicine, McGill University Health Center, McGill University, Royal Victoria Hospital, Montreal, Que
    CMAJ 169:1153-7. 2003
    ..Whether physicians and patients follow this recommendation is unknown. Our objective was to determine the rate at which patients fill at least one prescription for cholesterol-lowering medications after coronary revascularization...
  22. ncbi The dollars and sense of drug-eluting stents
    James M Brophy
    Division of Cardiology and Clinical Epidemiology, McGill University Health Centre Technology Assessment Unit, Royal Victoria Hospital, , Que
    CMAJ 172:361-2. 2005
  23. ncbi Evidence for use of coronary stents. A hierarchical bayesian meta-analysis
    James M Brophy
    McGill University, Montreal, Quebec, Canada
    Ann Intern Med 138:777-86. 2003
    ....
  24. ncbi Misplaced pacemaker wire as a cause of mitral regurgitation
    J M Brophy
    Heart 89:246. 2003
  25. ncbi Medical decision making in the choice of a thrombolytic agent for acute myocardial infarction. Quebec Acute Coronary Care Working Group
    J M Brophy
    Department of Medicine of Centre Hospitalier de l Université de Montreal, Quebec, Canada
    Med Decis Making 19:411-8. 1999
    ..However, they also preferentially treated younger patients, where only a small absolute advantage appears to exist...
  26. ncbi Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study
    M Etminan
    Center for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
    Aliment Pharmacol Ther 29:1188-92. 2009
    ..Similarly, the risk of UGB among users of both bisphosphonates and non steroidal anti-inflammatory drugs (NSAIDs) in the community is also unknown...
  27. ncbi Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs
    Christine G St Germaine
    Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
    Am J Cardiol 105:1740-5. 2010
    ....
  28. ncbi Investigation of an interaction between statins and clopidogrel after percutaneous coronary intervention: a cohort study
    Ana Blagojevic
    Department of Medicine, McGill University Health Center, Quebec, Canada
    Pharmacoepidemiol Drug Saf 18:362-9. 2009
    ..Previous studies have suggested that some statins may inhibit the antiplatelet effects of clopidogrel via competitive metabolism of its activating enzyme cytochrome P450 3A4 (CYP3A4)...
  29. ncbi A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents
    Mohan N Babapulle
    Division of Cardiology, Royal Victoria Hospital/McGill University Health Center, Montreal, Quebec, Canada
    Lancet 364:583-91. 2004
    ..They also appear to be safe in the short to medium term, although definitive conclusions are not possible. Larger studies with longer follow-up are needed to define better the role of these new devices...
  30. ncbi Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis
    Verena Schneider
    Division of Clinical Epidemiology, Royal Victoria Hospital, Department of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Montreal, Quebec, Canada
    Am J Epidemiol 164:881-9. 2006
    ..54, 95% CI: 1.14, 2.09; test for interaction comparing celecoxib with rofecoxib, p = 0.057). There was a significant association for both selective and nonselective NSAIDs with acute renal failure, but confirmatory studies are required...
  31. ncbi Fluctuating inflammatory markers in patients with stable ischemic heart disease
    Peter Bogaty
    Quebec Heart Institute, Laval Hospital, Laval University, Quebec City, Quebec, Canada
    Arch Intern Med 165:221-6. 2005
    ..However, little is known about how inflammatory markers fluctuate over time in patients with stable ischemic heart disease...
  32. ncbi Public policy and coronary stenting: a different perspective
    J M Brophy
    Department of Medicine, Centre Hospitalier Angrignon, Verdun, Quebec
    Can J Cardiol 14:54-7. 1998
    ..Further research is required to ascertain fully the safety, efficacy and cost effectiveness of coronary stenting in routine practice before public policy can be formulated sensibly...
  33. ncbi Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study
    Kristian B Filion
    Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, 1020 Pine Avenue West Montreal, Quebec H3A 1A2, Canada
    Int J Technol Assess Health Care 25:151-60. 2009
    ..Recent studies suggest that microvolt T-wave alternans (MTWA) predicts mortality and severe arrhythmic events in this population. However, the impact of MTWA on ICD cost-effectiveness is unknown...
  34. ncbi Shortness of breath at night and health status in congestive heart failure: effects of environmental conditions and health-related and dietary factors
    Mark S Goldberg
    Department of Medicine, McGill University, 687 Pine Ave W, Montreal, Quebec, Canada H3A 1A1
    Environ Res 109:166-74. 2009
    ....
  35. ncbi Clinical utility of C-reactive protein measured at admission, hospital discharge, and 1 month later to predict outcome in patients with acute coronary disease. The RISCA (recurrence and inflammation in the acute coronary syndromes) study
    Peter Bogaty
    Quebec Heart Institute Laval Hospital, Laval University, Quebec City, Quebec, Canada
    J Am Coll Cardiol 51:2339-46. 2008
    ....
  36. ncbi Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis
    Kristian B Filion
    Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada
    Pharmacoepidemiol Drug Saf 18:973-6. 2009
    ..The objective of this study was to describe trends in the prescription of anti-diabetic medications among patients with type 2 diabetes in the United Kingdom (UK)...
  37. ncbi The cost-effectiveness of Maze procedures using ablation techniques at the time of mitral valve surgery
    Stéphane P Quenneville
    Department of Cardiology, Royal Victoria Hospital, McGill University Health Centre, Quebec, Canada
    Int J Technol Assess Health Care 25:485-96. 2009
    ..This study sought to systematically review the efficacy and safety of these newer techniques and to evaluate their long-term cost-effectiveness at the time of scheduled mitral valve (MV) surgery...
  38. ncbi Therapeutic management in patients with renal failure who experience an acute coronary syndrome
    Heloise Cardinal
    Centre Hospitalier de l Universite de Montreal, 1058 Saint Denis, Montreal, Quebec, Canada, H2X 3J4
    Clin J Am Soc Nephrol 5:87-94. 2010
    ..The aim of this study was to determine whether this held true in a contemporary cohort, after thorough adjustment for cotreatments/comorbidities...
  39. ncbi Usefulness of soluble fas levels for improving diagnostic accuracy and prognosis for acute coronary syndromes
    Heloise Cardinal
    Department of Medicine, Centre Hospitalier de l Universite de Montreal, Montreal, Quebec, Canada
    Am J Cardiol 105:797-803. 2010
    ..In conclusion, our results suggest that in suspected ACS cases, sFas, but not hs-CRP, helps to improve the diagnostic accuracy and timeliness over and above standard diagnostic criteria...
  40. ncbi Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review
    Nandini Dendukuri
    Technology Assessment Unit, McGill University Health Centre, McGill University, Montreal, Que
    CMAJ 173:167-70. 2005
    ..We performed a systematic review of randomized controlled trials to assess the effectiveness of probiotic therapy...
  41. ncbi End-user involvement in health technology assessment (HTA) development: a way to increase impact
    Maurice McGregor
    Department of Medicine, Division of Cardiology, McGill University and McGill University Health Centre, Montreal, Quebec, Canada
    Int J Technol Assess Health Care 21:263-7. 2005
    ..A mechanism to increase the influence of Health Technology Assessments (HTAs) on hospital policy decisions was developed...
  42. ncbi Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial
    Anique Ducharme
    Department of Medicine, Montreal Heart Institute, University of Montreal, Que
    CMAJ 173:40-5. 2005
    ..When our results are integrated with those from other, similar trials, multidisciplinary disease management strategies for congestive heart failure are associated with clinically worthwhile improvements in survival...
  43. ncbi A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction
    James M Brophy
    Division of Cardiology and Clinical Epidemiology, McGill University Health Center, Montreal, Quebec, Canada
    Am J Med 116:300-4. 2004
    ..Heart failure is a leading cause of morbidity and mortality, but there are no reliable models based on readily available clinical variables to predict outcomes in patients taking angiotensin-converting enzyme (ACE) inhibitors...
  44. ncbi Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding
    Joseph A Delaney
    Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Que
    CMAJ 177:347-51. 2007
    ..We assessed whether antithrombotic drug combinations increased the risk of such bleeding in a general practice population...
  45. ncbi Discontinuation of statin therapy following an acute myocardial infarction: a population-based study
    Stella S Daskalopoulou
    Division of Internal Medicine, Department of Medicine, McGill University, McGill University Health Centre, Montreal General Hospital, 1650 Cedar Avenue, B2 236, Montreal, QC, Canada
    Eur Heart J 29:2083-91. 2008
    ..Our objective was to estimate the extent to which different patterns of statin use are associated with post-AMI mortality...
  46. ncbi Beta-blockers in congestive heart failure. A Bayesian meta-analysis
    J M Brophy
    Service de cardiologie, Centre Hospitalier de l Universite de Montreal, Pavillon Notre Dame, 1560 rue Sherbrooke Est, Montreal, Quebec H2L 4M1, Canada
    Ann Intern Med 134:550-60. 2001
    ..Although several randomized clinical trials have compared beta-blockers with placebo for treatment of congestive heart failure, a meta-analysis quantifying the effect on mortality and morbidity has not been performed recently...
  47. ncbi Use of abciximab (c7E3 Fab, ReoPro) as an adjunct to balloon angioplasty
    M McGregor
    McGill University Health Centre, Montreal, Quebec
    Can J Cardiol 15:201-7. 1999
    ..To estimate the magnitude of the clinical benefits that may result from use of abciximab at the time of angioplasty and the cost of achieving them...
  48. ncbi The epidemiology of acute myocardial infarction and ischemic heart disease in Canada: data from 1976 to 1991
    J M Brophy
    Department of Medicine, Centre Hospitalier Angrignon, Verdun, Quebec
    Can J Cardiol 13:474-8. 1997
    ..To present national trends in mortality rates for myocardial infarction and cardiovascular disease...
  49. ncbi The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database
    Kristian B Filion
    McGill University, Division of Clinical Epidemiology, Royal Victoria Hospital, Montreal, Canada
    Pharmacoepidemiol Drug Saf 16:1-4. 2007
    ..We assessed the impact of this policy change on statin prescribing...
  50. ncbi A panel study in congestive heart failure to estimate the short-term effects from personal factors and environmental conditions on oxygen saturation and pulse rate
    M S Goldberg
    Department of Medicine, Division of Clinical Epidemiology, McGill University Health Centre, 687 Pine Avenue West, R4 29, Montreal, Quebec H3A1A1
    Occup Environ Med 65:659-66. 2008
    ..This daily diary panel study in Montreal, Quebec, was carried out to determine whether oxygen saturation and pulse rate were associated with selected personal factors, weather conditions and air pollution...
  51. ncbi Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease
    G B John Mancini
    Division of Cardiology, Vancouver Hospital, Jack Bell Research Centre, University of British Columbia, Vancouver, British Columbia, Canada
    J Am Coll Cardiol 47:2554-60. 2006
    ....
  52. ncbi ACE-inhibitor use and the long-term risk of renal failure in diabetes
    S Suissa
    The Department of Epidemiology and Biostatistics, Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University Health Centre, 687 Pine Avenue West, Ross 429, Montreal, Quebec, Canada H3A 1A1
    Kidney Int 69:913-9. 2006
    ..Our data suggest instead that ACE inhibitors might actually increase this risk, which may possibly contribute to the continued increasing incidence of ESRD owing to diabetes...
  53. ncbi Treating the right patient at the right time: access to heart failure care
    H Ross
    Department of Medicine, University Health Network, University of Toronto, Toronto, Canada
    Can J Cardiol 22:749-54. 2006
    ....
  54. ncbi The cost-effectiveness of stem cell transplantations from unrelated donors in adult patients with acute leukemia
    Vania Costa
    Technology Assessment Unit, McGill University Health Centre, Montreal, QC, Canada
    Value Health 10:247-55. 2007
    ....
  55. ncbi Canadian Cardiovascular Society commentary on implantable cardioverter defibrillators in Canada: waiting times and access to care issues
    C S Simpson
    Department of Medicine, Division of Cardiology, Queen s University, Kingston, Ontario
    Can J Cardiol 21:19A-24A. 2005
    ..A maximum recommended waiting time is proposed and the framework for a solution-oriented approach is presented...
  56. ncbi Geographical variations in post myocardial infarction mortality and their impact on risk selection
    Abdelouahed Naslafkih
    Faculty of Graduate Studies, University of Montreal, Montreal, Quebec, Canada
    J Insur Med 36:282-91. 2004
    ..This highlights the interest of risk assessment using mortality analysis methodology, which makes the geographic variation in post-myocardial infarction mortality disappear...
  57. ncbi A meta-analysis of antibiotic use for the secondary prevention of cardiovascular diseases
    Zhi Song
    Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec
    Can J Cardiol 24:391-5. 2008
    ..However, results have occasionally been conflicting, and a meta-analysis may provide additional clarification...
  58. ncbi Primary PCI in ST-segment elevation myocardial infarction
    Peter Bogaty
    N Engl J Med 358:1751; author reply 1752-3. 2008
  59. ncbi The cost-effectiveness of drug-eluting stents: a systematic review
    Suzanne Ligthart
    Department of Medical Technology Assessment, University Medical Centre Nijmegen, Nijmegen, The Netherlands
    CMAJ 176:199-205. 2007
    ..We conducted a systematic review of all published comparative cost-effectiveness analyses to identify the factors contributing to the heterogeneity of their conclusions...
  60. ncbi Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study
    Peter Bogaty
    Quebec Heart Institute Laval Hospital, Laval University, 2725 Chemin Ste Foy, Quebec City, Quebec, Canada G1V 4G5
    Circulation 110:934-9. 2004
    ..We investigated the effect of prolonged COX-2 inhibition on inflammatory profile and endothelial function in patients with ischemic heart disease and high serum C-reactive protein (CRP) values...
  61. ncbi GRACIA: implications for clinical practice
    Peter Bogaty
    Lancet 365:381; author reply 382. 2005
  62. ncbi Treating the right patient at the right time: access to specialist consultation and non-invasive testing
    Merril L Knudtson
    Libin Cardiovascular Institute of Alberta
    Can J Cardiol 22:819-24. 2006
    ....
  63. ncbi Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study
    Mahyar Etminan
    Center for Clinical Epidemiology and Evaluation, Vancouver General Hospital, Vancouver, British Columbia, Canada
    Pharmacotherapy 26:479-82. 2006
    ..In addition, the putative protection against pneumonia may instead be related to general inhibition of the renin-angiotensin system...
  64. ncbi Use of statins and angiotensin converting enzyme inhibitors (ACE-Is) and the risk of age-related macular degeneration: nested case-control study
    Mahyar Etminan
    Centre for Clinical Epidemiology and Evaluation, Vancouver General Hospital, 7 Floor 828 West 10 Ave, Vancouver, British Columbia, Canada
    Curr Drug Saf 3:24-6. 2008
    ..We sought to further explore this association and also explore the role of angiotensin-converting enzyme inhibitors (ACE-Is) with respect to the development of AMD...
  65. ncbi Cardiovascular risk associated with celecoxib
    James M Brophy
    N Engl J Med 352:2648-50; author reply 2648-50. 2005
  66. ncbi Confounding in database pharmacoepidemiology studies
    Joseph A C Delaney
    Epidemiology 19:360-1. 2008
  67. ncbi Primary data collection in health technology assessment
    Michelle L McIsaac
    McGill University and University of Montreal Health Centres, and Department of Community Health Sciences, University of Calgary, 1403 29 Street NW, Calgary, Alberta, Canada
    Int J Technol Assess Health Care 23:24-9. 2007
    ..The authors conclude that, under specific conditions, primary data collection is a worthwhile endeavor in the HTA process...
  68. ncbi Rehabilitating digoxin
    James M Brophy
    Eur Heart J 27:127-9. 2006
  69. ncbi Vaccination against human papillomavirus
    James M Brophy
    CMAJ 177:1525-6; author reply 1527-8. 2007
  70. ncbi Has thrombolysis lost its mojo?
    James M Brophy
    Heart 93:1167-9. 2007
  71. ncbi Friendly fire and continuing medical education
    James M Brophy
    Can J Cardiol 21:23-4. 2005
  72. ncbi Selling safety--lessons from muraglitazar
    James M Brophy
    JAMA 294:2633-5. 2005
  73. ncbi Risk stratification following non-ST segment elevation myocardial infarction: is the glass half-full or half-empty?
    James M Brophy
    Can J Cardiol 23:1080-1. 2007
  74. ncbi Use of oral bisphosphonates and the risk of aseptic osteonecrosis: a nested case-control study
    Mahyar Etminan
    Center for Clinical Epidemiology and Evaluation, Vancouver General Hospital, Vancouver, BC, Canada
    J Rheumatol 35:691-5. 2008
    ..To determine whether use of oral bisphosphonates is associated with an increased risk of aseptic osteonecrosis (AON) among a cohort of elderly cardiovascular patients...
  75. ncbi Primary angioplasty or thrombolysis? A topical parable
    Peter Bogaty
    Quebec Heart Institute, Laval University, Ste-Foy, Quebec, Canada G1V 4G5
    BMJ 328:1257-8. 2004